🇺🇸 FDA
Patent

US 9765123

Pseudomonas exotoxin a with less immunogenic T cell and/or B cell epitopes

granted A61KA61K38/00A61P

Quick answer

US patent 9765123 (Pseudomonas exotoxin a with less immunogenic T cell and/or B cell epitopes) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Sep 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K38/00, A61P, A61P35/00, A61P35/02